Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 19;11(3):e00907-20.
doi: 10.1128/mBio.00907-20.

Could an Unrelated Live Attenuated Vaccine Serve as a Preventive Measure To Dampen Septic Inflammation Associated with COVID-19 Infection?

Affiliations

Could an Unrelated Live Attenuated Vaccine Serve as a Preventive Measure To Dampen Septic Inflammation Associated with COVID-19 Infection?

Paul L Fidel Jr et al. mBio. .

Abstract

We propose the concept that administration of an unrelated live attenuated vaccine, such as MMR (measles, mumps, rubella), could serve as a preventive measure against the worst sequelae of coronavirus disease 2019 (COVID-19). There is mounting evidence that live attenuated vaccines provide nonspecific protection against lethal infections unrelated to the target pathogen of the vaccine by inducing "trained" nonspecific innate immune cells for improved host responses against subsequent infections. Mortality in COVID-19 cases is strongly associated with progressive lung inflammation and eventual sepsis. Vaccination with MMR in immunocompetent individuals has no contraindications and may be especially effective for health care workers who can easily be exposed to COVID-19. Following the lead of other countries conducting clinical trials with the live attenuated Mycobacterium bovis BCG (BCG) vaccine under a similar concept, a clinical trial with MMR in high-risk populations may provide a "low-risk-high-reward" preventive measure in saving lives during this unprecedented COVID-19 pandemic.

Keywords: COVID-19; MMR; clinical trial; inflammation; live attenuated vaccines; myeloid-derived suppressor cells; sepsis; trained innate immunity.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Protection against lethal polymicrobial-community-mediated sepsis by vaccination with an avirulent yeast strain. Mice were vaccinated intraperitoneally with avirulent (live attenuated) Candida dubliniensis (Cd) followed by a lethal challenge with Candida albicans and Staphylococcus aureus (Ca/Sa) intraperitoneally 14 days later. Survival data are shown for 8 independent experiments performed with groups of 10 mice each. The inset shows sepsis scoring during the observation period after lethal challenge. Animals were monitored daily using a modified mouse clinical assessment score for sepsis (M-CASS) scoring system that included fur aspect, posture, activity, and chest and eyelid movement. Animals with a combined daily score of 8+ were humanely euthanized. Data were statistically analyzed using the Mantel-Cox log rank test (survival curves) and two-way analysis of variance (ANOVA) with Bonferroni post hoc tests (sepsis scoring) (****, P < 0.0001). SEM, standard errors of the means.

Comment in

Similar articles

Cited by

References

    1. Aaby P, Benn CS. 2019. Developing the concept of beneficial non-specific effect of live vaccines with epidemiological studies. Clin Microbiol Infect 25:1459–1467. doi:10.1016/j.cmi.2019.08.011. - DOI - PubMed
    1. Moorlag S, Arts RJW, van Crevel R, Netea MG. 2019. Non-specific effects of BCG vaccine on viral infections. Clin Microbiol Infect 25:1473–1478. doi:10.1016/j.cmi.2019.04.020. - DOI - PubMed
    1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, J Xu, Tu S, Zhang Y, Chen H, Cao B. 2020. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395 doi:10.1016/S0140-6736(20)30566-3. - DOI - PMC - PubMed
    1. Kaufmann E, Sanz J, Dunn JL, Khan N, Mendonça LE, Pacis A, Tzelepis F, Pernet E, Dumaine A, Grenier J-C, Mailhot-Léonard F, Ahmed E, Belle J, Besla R, Mazer B, King IL, Nijnik A, Robbins CS, Barreiro LB, Divangahi M. 2018. BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell 172:176–190.e19. doi:10.1016/j.cell.2017.12.031. - DOI - PubMed
    1. Lilly EA, Ikeh M, Nash EE, Fidel PL Jr, Noverr MC. 2018. Immune protection against lethal fungal-bacterial intra-abdominal infections. mBio 9:e01472-17. doi:10.1128/mBio.01472-17. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources